Our top pick for
Stoneridge, Inc is an auto parts business based in the US. Stoneridge shares (SRI) are listed on the NYSE and all prices are listed in US Dollars. Stoneridge employs 4,700 staff and has a trailing 12-month revenue of around USD$648.6 million.
Since the stock market crash in March caused by coronavirus, Stoneridge's share price has had significant negative movement.
Its last market close was USD$26.51, which is 10.50% down on its pre-crash value of USD$29.62 and 90.17% up on the lowest point reached during the March crash when the shares fell as low as USD$13.94.
If you had bought USD$1,000 worth of Stoneridge shares at the start of February 2020, those shares would have been worth USD$532.89 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$942.43.
|Latest market close||USD$26.51|
|52-week range||USD$13.87 - USD$32.27|
|50-day moving average||USD$23.3942|
|200-day moving average||USD$20.9514|
|Wall St. target price||USD$28.5|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$1.943|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-16)||N/A|
|1 month (2020-10-27)||18.03%|
|3 months (2020-08-23)||N/A|
|6 months (2020-05-23)||N/A|
|1 year (2019-11-23)||N/A|
|2 years (2018-11-23)||N/A|
|3 years (2017-11-23)||N/A|
|5 years (2015-11-23)||N/A|
Valuing Stoneridge stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Stoneridge's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Stoneridge's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Stoneridge shares trade at around 10x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Stoneridge's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 53.46. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Stoneridge's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Stoneridge's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$31.4 million.
The EBITDA is a measure of a Stoneridge's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$648.6 million|
|Gross profit TTM||USD$221.4 million|
|Return on assets TTM||-0.07%|
|Return on equity TTM||-2.71%|
|Market capitalisation||USD$710.8 million|
TTM: trailing 12 months
There are currently 561,091 Stoneridge shares held short by investors – that's known as Stoneridge's "short interest". This figure is 54.8% up from 362,444 last month.
There are a few different ways that this level of interest in shorting Stoneridge shares can be evaluated.
Stoneridge's "short interest ratio" (SIR) is the quantity of Stoneridge shares currently shorted divided by the average quantity of Stoneridge shares traded daily (recently around 128102.96803653). Stoneridge's SIR currently stands at 4.38. In other words for every 100,000 Stoneridge shares traded daily on the market, roughly 4380 shares are currently held short.
However Stoneridge's short interest can also be evaluated against the total number of Stoneridge shares, or, against the total number of tradable Stoneridge shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Stoneridge's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Stoneridge shares in existence, roughly 20 shares are currently held short) or 0.0217% of the tradable shares (for every 100,000 tradable Stoneridge shares, roughly 22 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Stoneridge.
Find out more about how you can short Stoneridge stock.
We're not expecting Stoneridge to pay a dividend over the next 12 months.
Stoneridge's shares were split on a 5:9 basis on 22 March 2011. So if you had owned 9 shares the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Stoneridge shares – just the quantity. However, indirectly, the new 80% higher share price could have impacted the market appetite for Stoneridge shares which in turn could have impacted Stoneridge's share price.
Over the last 12 months, Stoneridge's shares have ranged in value from as little as $13.87 up to $32.27. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Stoneridge's is 1.5547. This would suggest that Stoneridge's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Stoneridge, Inc., together with its subsidiaries, designs and manufactures engineered electrical and electronic components, modules, and systems for the automotive, commercial, off-highway, motorcycle, and agricultural vehicle markets. The company operates in three segments: Control Devices, Electronics, and Stoneridge Brazil. The Control Devices segment offers sensors, switches, and actuators that monitor, measure, or activate specific functions within a vehicle. The Electronics segment designs and manufactures driver information systems, camera-based vision systems, connectivity, compliance products, and electronic control units. Its products collect, store, and display vehicle information, such as speed, pressure, maintenance data, trip information, operator performance, temperature, distance traveled, and driver messages related to vehicle performance. This segment's power distribution modules and systems regulate, coordinate, monitor, and direct the operation of the electrical system within a vehicle. The Stoneridge Brazil segment design, manufacture and sell vehicle tracking devices and monitoring services; vehicle security alarms and convenience accessories; in-vehicle audio and infotainment devices; and telematics solutions. It provides its products and systems to various original equipment manufacturers and tier 1 customers, as well as aftermarket distributors and mass merchandisers for use in various vehicle platforms. It serves in North America, South America, Europe, and internationally. Stoneridge, Inc. was founded in 1965 and is headquartered in Novi, Michigan.
Everything we know about the NewRez IPO, plus information on how to buy in.
Everything we know about the Perella Weinberg IPO, plus information on how to buy in.
Everything we know about the Nanobiotix IPO, plus information on how to buy in.
Everything we know about the Diversey IPO, plus information on how to buy in.
Everything we know about the Certara IPO, plus information on how to buy in.
Everything we know about the Arrival IPO, plus information on how to buy in.
Everything we know about the iSpecimen IPO, plus information on how to buy in.
Everything we know about the IDEX Biometrics ASA IPO, plus information on how to buy in.
Steps to owning and managing MYSZ, with 24-hour and historical pricing before you buy.
Steps to owning and managing MG, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.